Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute one of the first obstacles facingnanomedicines or other nanoparticles entering organisms. It is thus important to assess the capacity of nanoparticles to enter andtransport across such barriers. In this work, Caco-2 intestinal epithelial cells were used as a well-established model for the intestinalbarrier, and the uptake, trafficking and translocation of model silica nanoparticles of different sizes were investigated using a com-bination of imaging, flow cytometry and transport studies. Compared to typical observations in standard cell lines commonly usedfor in vitro studies, silica nanoparticle uptake into well-developed Caco-2 cellular barri...
This work examines the potential drug delivery barrier of the basement membrane (BM) by assessing th...
Solid lipid nanoparticles (SLNs) have been extensively investigated and demonstrated to be a potenti...
Nanoparticles (NPs) are in clinical use or under development for therapeutic imaging and drug delive...
Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute on...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
In order to improve the current success of nanomedicine, a better understanding of how nano-sized ma...
An in vitro model of the human follicle associated epithelium (FAE) was characterized and the influe...
AbstractDrug and gene delivery via nanoparticles across biological barriers such as the alveolar-cap...
Micro and nano-particulate carriers have potential to increase bioavailability of oral drugs, but mu...
The study of nanomaterial translocation across epithelial barriers is often hindered by the low perm...
Background: The omnipresence of nanoparticles (NPs) in numerous goods has led to a constant risk of ...
We aimed to obtain a tunable intestinal model and study the transport of different types of nanopart...
International audienceInhalation is the most frequent route of unintentional exposure to nanoparticl...
This work examines the potential drug delivery barrier of the basement membrane (BM) by assessing th...
Solid lipid nanoparticles (SLNs) have been extensively investigated and demonstrated to be a potenti...
Nanoparticles (NPs) are in clinical use or under development for therapeutic imaging and drug delive...
Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute on...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
This study investigated the effect of nanoparticle size (50 and 100 nm) and surface charge on their ...
In order to improve the current success of nanomedicine, a better understanding of how nano-sized ma...
An in vitro model of the human follicle associated epithelium (FAE) was characterized and the influe...
AbstractDrug and gene delivery via nanoparticles across biological barriers such as the alveolar-cap...
Micro and nano-particulate carriers have potential to increase bioavailability of oral drugs, but mu...
The study of nanomaterial translocation across epithelial barriers is often hindered by the low perm...
Background: The omnipresence of nanoparticles (NPs) in numerous goods has led to a constant risk of ...
We aimed to obtain a tunable intestinal model and study the transport of different types of nanopart...
International audienceInhalation is the most frequent route of unintentional exposure to nanoparticl...
This work examines the potential drug delivery barrier of the basement membrane (BM) by assessing th...
Solid lipid nanoparticles (SLNs) have been extensively investigated and demonstrated to be a potenti...
Nanoparticles (NPs) are in clinical use or under development for therapeutic imaging and drug delive...